Pacemaker Devices Market Size to Grow Exponentially during 2017 - 2022
Here are the key insights into the global pacemaker devices market:
Rising support to the medical devices industry is likely to remain vital for the global pacemaker devices market in the coming years. Several governments across the world have begun to invest in the medical device sector as well as the healthcare research sector due to the strong benefits to the economy as well as to the region’s healthcare sector due to the indigenous production of medical devices and technology.
View and Download TOC of Pacemaker Devices Market Research Report@ https://www.transparencymarketresearch.com/report-toc/6586
The rising incorporation of modern connectivity features in pacemakers is likely to help the global pacemaker devices market’s growth. Smartphone connectivity can allow users to keep track of their or a loved one’s heart rate, while calling the physician in cases of emergency has also become easier due to the technological progression of modern pacemaker devices. Technological progression is likely to remain a key driver for the global pacemaker devices market in the coming years due to the rapid entry of several new players in the medical device sector and the easy availability of advanced medical technology for incorporation in new medical devices.
Geographically, North America is likely to dominate the global pacemaker devices market in the coming years due to the rising prevalence of cardiac problems in developed countries such as the U.S., the high number of medical device manufacturers located in the region, and the increasing support for adoption of technologically advanced pacemaker devices in the healthcare sector. The steady support given by the government in the U.S. and Canada, both of which rank among the most lucrative locations for medical device companies, is likely to drive the global pacemaker devices market at a steady rate in North America in the coming years. The North America market for pacemaker devices is expected to rise from US$1.9 bn to US$2.9 bn over the 2017-2022 forecast period at a robust CAGR of 8.7%.
Asia Pacific except Japan is a relatively minor contributor to the global pacemaker devices market at present. However, the rising prevalence of cardiac diseases in Southeast Asia is likely to lead to rising demand for pacemaker devices, while the rising disposable income of consumers in APAC countries such as China, India, Malaysia, Thailand, and Indonesia could help enable steady adoption of technologically advanced pacemaker devices. The APEJ pacemaker devices market is expected to exhibit a 8.3% CAGR over the 2017-2022 forecast period and reach a valuation of US$1.7 bn by 2022.
Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6586
The global pacemaker devices market is moderately fragmented due to the dominance of established medical industry giants. However, a rising number of specialist players could enter the pacemaker devices market in the coming years. Leading companies in the global pacemaker devices market include Abbott Laboratories, Medtronic Plc., Oscor Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology, OSYPKA AG, Zoll Medical Corporation, and Pacetronix Limited.
Pacemaker devices are a set of devices used to regulate the heartbeat of cardiac patients. Pacemakers have long been a vital part of the cardiac disease treatment sector, but steady technological progression has brought about new generations of pacemaker devices with impressive new features and ergonomic comfort. This is likely to remain a key factor for the global pacemaker devices market, as the market surges due to the growing prevalence of cardiac diseases across the world. Developed regions such as North America and Europe are likely to dominate the global pacemaker devices market, with developing regions such as APEJ and MEA unlikely to feature as dominant contributors in the coming years.
Buy Full Pacemaker Devices Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=6586<ype=S
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pacemaker Devices Market Size to Grow Exponentially during 2017 - 2022 here
News-ID: 746456 • Views: 96
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Pacemaker
Global Temporary Pacemaker Market Research Report
This report studies the global Temporary Pacemaker market status and forecast, categorizes the global Temporary Pacemaker market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Medtronic Osypka Medical Biotronik St.Jude Medical Shree Pacetronix Oscor Cardiologic Geographically, this report studies the top producers
Global Pacemaker Devices Market Research
A Global Pacemaker Devices Market is a little gadget that is utilized to manage your heart musicality. The Global Pacemaker Devices Market advertise has been assessed as consistently developing business sector and it is normal that the market will keep on developing correspondingly soon. Cardiovascular pacemaker are the fake heart cadence the board gadgets which regularize the pulses by sending the electrical driving forces to the heart. Outside pacemakers are
Cardiac Pacemaker Market: Asia Pacific Shows High Growth Scope in Cardiac Pacema …
The global cardiac pacemakers market is predicted to witness a substantial growth in the forthcoming years, according to Transparency Market Research (TMR). The market is featured by the presence of three leading companies, namely Boston Scientific, Medtronic and St. Jude Medical, who cumulatively hold over 76% of the total market share. The industry is marked with high competition between the leading players. Medtronic, a leading player, has gained a high
Global Pacemaker Devices Market: Trends and Opportunities
The vendor landscape of the global pacemaker devices market is moderately fragmented, thanks to the presence of several established medical companies, observes Transparency Market Research (TMR) in a recent report. In the next few years, the market is likely to become more crowded and competitive owing to the rising number of specialist players in the market globally. To remain competitive in such intense dynamics, companies have begun focusing more on
Pacemaker Devices Market: Global Forecast over 2022
According to Transparency Market Research, the global pacemaker devices market was valued at US$5.5 bn in 2017 and is expected to rise to US$8.1 bn by 2022. Here are the key insights into the global pacemaker devices market: Rising support to the medical devices industry is likely to remain vital for the global pacemaker devices market in the coming years. Several governments across the world have begun to invest in the medical
Global Heart Pacemaker Sales Market Report 2017
As a rule, an organic pacemaker is at least one writes of cell parts that, when "embedded or infused into specific locales of the heart," deliver particular electrical boosts that copy that of the body's characteristic pacemaker cells. It's shown for issues, for example, heart piece, moderate heart rate, and nonconcurrent heart ventricle constrictions In this report, the global Heart Pacemaker market is valued at USD XX million in 2016 and